Trending Now
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Completes the Acquisition of SmartPharm to Advance...
Since its establishment in 2009, Sorrento Therapeutics Inc. (NASDAQ:SRNE) has had a long journey of discovering diversified therapies for managing cancer and possibly curable...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Incyte Corporation (NASDAQ: INCY) Enters License Collaboration Agreement With InnoCare Subsidiary...
Incyte Corporation (NASDAQ: INCY) and InnoCare have announced that Incyte and an InnoCare subsidiary have signed a collaboration and license agreement to develop and...
MAKE IT MODERN
LATEST REVIEWS
Novabay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) Enters Agreement For Distribution Of Avenova In...
Novabay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) has entered an exclusive agreement with Paragon Care Group Australia Pty Ltd for the distribution of Avenova in Australia. According...
MAKE IT MODERN
PERFORMANCE TRAINING
iBio Inc. (NYSEAMERICAN: IBIO) Announces Fiscal Q1 2022 Financial Results and Partnership To Study...
iBio Inc. (NYSEAMERICAN: IBIO) has announced its Q1 2022 financial result and offered a corporate update. Revenues during the quarter dropped 49% YoY to...
Why Crypto Stocks May be the Best Route to Monetizing the Bitcoin Bear (SDIG,...
Bitcoin has been in another major bear market over recent months (1). But, as any experienced investor knows, bear markets and bull markets come...
Omicron Minimally Impacts SARS-CoV-2 T Cell Epitopes Within Gritstone Bio Inc.’s (NASDAQ: GRTS) mRNA...
Gritstone Bio Inc. (NASDAQ: GRTS) has announced that the SARS-CoV-2 T Cell epitopes given within the company’s self-amplifying mRNA COVID vaccines experience minimal impact...
Actinium Pharmaceuticals Inc (NYSE: ATNM) and Immedica Biopharma partner on Iomab-B
Immedica Biopharma and Actinium Pharmaceuticals Inc (NYSE: ATNM) have entered a supply and license agreement. Their agreement involves Iomab-B that Actinium created...
Mustang Bio Inc. (NASDAQ:MBIO) Enters Agreement With SIRION For LentiBOOST™ Tech And Starts Dosing...
Mustang Bio Inc. (NASDAQ:MBIO) has announced a license agreement with SIRION Biotech GmbH under which Mustang acquired rights to the LentiBOOST™ technology from SIRION....
MAKE IT MODERN
